{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:58:16Z","timestamp":1787702296499,"version":"build-2784847793"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Centers for Disease Control and Prevention\u2019s Prevention Epicenters Program","award":["U01CK000554-02-02"],"award-info":[{"award-number":["U01CK000554-02-02"]}]},{"name":"Centers for Disease Control and Prevention\u2019s Prevention Epicenters Program","award":["U54CK000617-01-00"],"award-info":[{"award-number":["U54CK000617-01-00"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prompt initiation of antibiotic therapy improves the survival of patients with bloodstream infections (BSIs). We sought to determine if the sequence of administration of the first dose of antibiotic therapy (ie, \u03b2-lactam or vancomycin, if both are deemed necessary and cannot be administered simultaneously) impacts early mortality for patients with BSI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a multicenter, observational study of patients \u226513 years with BSIs to evaluate the association of the sequence of antibiotic administration with 7-day mortality using inverse probability of treatment weighting (IPTW) incorporating propensity scores. Propensity scores were generated based on demographics, Pitt bacteremia score, intensive care unit status, highest lactate, highest white blood cell count, Charlson comorbidity index, severe immunocompromise, administration of active empiric therapy, combination therapy, and time from emergency department arrival to first antibiotic dose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 3376 eligible patients, 2685 (79.5%) received a \u03b2-lactam and 691 (20.5%) received vancomycin as their initial antibiotic. In the IPTW cohort, exposed and unexposed patients were similar on all baseline variables. Administration of a \u03b2-lactam agent prior to vancomycin protected against 7-day mortality (adjusted odds ratio [aOR], 0.48 [95% confidence interval {CI}, .33\u2013.69]). Similar results were observed when evaluating 48-hour mortality (aOR, 0.45 [95% CI, .24\u2013.83]). Administration of vancomycin prior to a \u03b2-lactam was not associated with improved survival in the subgroup of 524 patients with methicillin-resistant Staphylococcus aureus BSI (aOR, 0.93 [95% CI, .33\u20132.63]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>For ill-appearing patients likely to be experiencing a BSI, prioritizing administration of a \u03b2-lactam over vancomycin may reduce early mortality, underscoring the significant impact of a relatively simple practice change on improving patient survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciab865","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T16:36:06Z","timestamp":1633019766000},"page":"98-104","source":"Crossref","is-referenced-by-count":22,"title":["Administration of a \u03b2-Lactam Prior to Vancomycin as the First Dose of Antibiotic Therapy Improves Survival in Patients With Bloodstream Infections"],"prefix":"10.1093","volume":"75","author":[{"given":"Joe","family":"Amoah","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eili Y","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Chiotos","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care Medicine, Children\u2019s Hospital of Philadelphia , Philadelphia, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9458-4331","authenticated-orcid":false,"given":"Sara E","family":"Cosgrove","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranita D","family":"Tamma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,10,4]]},"reference":[{"key":"2022082503045026900_CIT0001","first-page":"B5128","article-title":"The incidence and prognosis of patients with bacteremia","volume":"62","author":"Nielsen","year":"2015","journal-title":"Dan Med J"},{"key":"2022082503045026900_CIT0002","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s10096-021-04215-4","article-title":"Attributable mortality of ICU acquired bloodstream infections: a propensity-score matched analysis","volume":"40","author":"Massart","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2022082503045026900_CIT0003","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1086\/500318","article-title":"Excess risk of death from intensive care unit\u2013acquired nosocomial bloodstream infections: a reappraisal","volume":"42","author":"Garrouste-Orgeas","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2022082503045026900_CIT0004","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/CCM.0000000000000688","article-title":"Antibiotic initiation in severe sepsis: does sequence impact outcome?","volume":"43","author":"Alhammad","year":"2015","journal-title":"Crit Care Med"},{"key":"2022082503045026900_CIT0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/infdis\/jiaa221","article-title":"Considerations for empiric antimicrobial therapy in sepsis and septic shock in an era of antimicrobial resistance","volume":"222","author":"Strich","year":"2020","journal-title":"J Infect Dis"},{"key":"2022082503045026900_CIT0006","doi-asserted-by":"crossref","first-page":"e00355","DOI":"10.1128\/AAC.00355-19","article-title":"The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program","volume":"63","author":"Diekema","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2022082503045026900_CIT0007","doi-asserted-by":"crossref","first-page":"e02671","DOI":"10.1128\/AAC.02671-16","article-title":"Results from a 13-year prospective cohort study show increased mortality associated with bloodstream infections caused by Pseudomonas aeruginosa compared to other bacteria","volume":"61","author":"Thaden","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2022082503045026900_CIT0008","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0732-8893(93)90109-K","article-title":"Effect of antibiotics on endotoxin release from gram-negative bacteria","volume":"16","author":"Eng","year":"1993","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2022082503045026900_CIT0009","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1542\/hpeds.2020-0125","article-title":"Replace red man syndrome with vancomycin flushing reaction","volume":"10","author":"Austin","year":"2020","journal-title":"Hosp Pediatr"},{"key":"2022082503045026900_CIT0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2022082503045026900_CIT0011","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/SHK.0b013e318182f98f","article-title":"Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems","volume":"31","author":"Rhee","year":"2009","journal-title":"Shock"},{"key":"2022082503045026900_CIT0012","volume-title":"Performance standards for antimicrobial susceptibility testing.","author":"Clinical and Laboratory Standards Institute.","year":"2021","edition":"31st ed."},{"key":"2022082503045026900_CIT0013","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"2022082503045026900_CIT0014","first-page":"e497","article-title":"Comparing propensity score methods versus traditional regression analysis for the evaluation of observational data: a case study evaluating the treatment of gram-negative bloodstream infections","volume":"71","author":"Amoah","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022082503045026900_CIT0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7883\/yoken1952.50.233","article-title":"Differential release of endotoxin from Pseudomonas aeruginosa treated with beta-lactam antibiotics and its effect on the lethal activity","volume":"50","author":"Narita","year":"1997","journal-title":"Jpn J Med Sci Biol"},{"key":"2022082503045026900_CIT0016","first-page":"3","article-title":"Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis","volume":"101","author":"Morrison","year":"1996","journal-title":"Scand J Infect Dis Suppl"},{"key":"2022082503045026900_CIT0017","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1203\/00006450-198603000-00008","article-title":"Protective effect of subinhibitory polymyxin B alone and in combination with ampicillin for overwhelming Haemophilus influenzae type B infection in the infant rat: evidence for in vivo and in vitro release of free endotoxin after ampicillin treatment","volume":"20","author":"Walterspiel","year":"1986","journal-title":"Pediatr Res"},{"key":"2022082503045026900_CIT0018","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/infdis\/150.3.380","article-title":"Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis","volume":"150","author":"Shenep","year":"1984","journal-title":"J Infect Dis"},{"key":"2022082503045026900_CIT0019","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/infdis\/167.6.1336","article-title":"Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli","volume":"167","author":"Evans","year":"1993","journal-title":"J Infect Dis"},{"key":"2022082503045026900_CIT0020","first-page":"378","article-title":"Effect of antibiotics and osmotic change on the release of endotoxin by bacteria retained on intravenous inline filters","volume":"32","author":"Rusmin","year":"1975","journal-title":"Am J Hosp Pharm"},{"key":"2022082503045026900_CIT0021","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s001340050877","article-title":"Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome","volume":"25","author":"Strutz","year":"1999","journal-title":"Intensive Care Med"},{"key":"2022082503045026900_CIT0022","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1093\/cid\/ciu612","article-title":"Antibiotic-resistant gram-negative bacterial infections in patients with cancer","volume":"59","author":"Perez","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2022082503045026900_CIT0023","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/QCO.0000000000000038","article-title":"Antimicrobial-resistant gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact","volume":"27","author":"Trecarichi","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"2022082503045026900_CIT0024","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","article-title":"Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance","volume":"32","author":"Montassier","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2022082503045026900_CIT0025","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","article-title":"Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients","volume":"19","author":"Gudiol","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"2022082503045026900_CIT0026","doi-asserted-by":"crossref","first-page":"ofy339","DOI":"10.1093\/ofid\/ofy339","article-title":"The role of ertapenem for the treatment of complicated intra-abdominal infections with a positive culture for Enterococcus faecalis","volume":"6","author":"Fabre","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2022082503045026900_CIT0027","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1155\/2014\/702621","article-title":"Mortality related to coagulase-negative staphylococcal bacteremia in febrile neutropenia: a cohort study","volume":"25","author":"Rosa","year":"2014","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2022082503045026900_CIT0028","doi-asserted-by":"crossref","first-page":"214","DOI":"10.15585\/mmwr.mm6809e1","article-title":"Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections\u2014United States","volume":"68","author":"Kourtis","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022082503045026900_CIT0029","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1007474","article-title":"Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections","volume":"364","author":"Jain","year":"2011","journal-title":"N Engl J Med"},{"key":"2022082503045026900_CIT0030","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1056\/NEJMoa061115","article-title":"An intervention to decrease catheter-related bloodstream infections in the ICU","volume":"355","author":"Pronovost","year":"2006","journal-title":"N Engl J Med"},{"key":"2022082503045026900_CIT0031","first-page":"22","article-title":"National costs associated with methicillin-susceptible and methicillin-resistant Staphylococcus aureus hospitalizations in the United States, 2010","volume":"68","author":"Klein","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022082503045026900_CIT0032","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jhq.12008","article-title":"A bundled approach to reduce methicillin-resistant Staphylococcus aureus infections in a system of community hospitals","volume":"35","author":"Perlin","year":"2013","journal-title":"J Healthc Qual"},{"key":"2022082503045026900_CIT0033","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1201-9712(00)90071-7","article-title":"Lincomycin-induced endotoxin release in Escherichia coli sepsis: evidence for release in vitro and in vivo","volume":"4","author":"Horii","year":"2000","journal-title":"Int J Infect Dis"},{"key":"2022082503045026900_CIT0034","first-page":"CD004386","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","volume":"1","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2022082503045026900_CIT0035","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/cncr.22205","article-title":"Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions","volume":"107","author":"Leibovici","year":"2006","journal-title":"Cancer"},{"key":"2022082503045026900_CIT0036","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jinf.2013.12.006","article-title":"Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients","volume":"68","author":"Mikulska","year":"2014","journal-title":"J Infect"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciab865\/40505931\/ciab865.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/1\/98\/45514249\/ciab865.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/1\/98\/45514249\/ciab865.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T23:08:24Z","timestamp":1661382504000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/1\/98\/6381106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,10,4]]},"published-print":{"date-parts":[[2022,8,24]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab865","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740921836.793595252","asserted-by":"object"}]},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2021,10,4]]}}}